AllianceBernstein’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-113,249
| Closed | -$2.2M | – | 3196 |
|
|
2018
Q1 | $2.2M | Hold |
113,249
| – | – | ﹤0.01% | 1761 |
|
|
2017
Q4 | $1.89M | Sell |
113,249
-90,520
| -44% | -$1.66M | ﹤0.01% | 1900 |
|
|
2017
Q3 | $4.14M | Buy |
203,769
+90,520
| +80% | +$1.73M | ﹤0.01% | 1336 |
|
|
2017
Q2 | $1.82M | Sell |
113,249
-12,500
| -10% | -$185K | ﹤0.01% | 1923 |
|
|
2017
Q1 | $1.59M | Hold |
125,749
| – | – | ﹤0.01% | 1967 |
|
|
2016
Q4 | $1.67M | Sell |
125,749
-91,780
| -42% | -$1.57M | ﹤0.01% | 1962 |
|
|
2016
Q3 | $5.16M | Buy |
217,529
+91,780
| +73% | +$2.47M | ﹤0.01% | 1112 |
|
|
2016
Q2 | $3.62M | Buy |
125,749
+5,100
| +4% | +$166K | ﹤0.01% | 1237 |
|
|
2016
Q1 | $3.86M | Hold |
120,649
| – | – | ﹤0.01% | 1159 |
|
|
2015
Q4 | $5.16M | Sell |
120,649
-700
| -0.6% | -$28K | ﹤0.01% | 1043 |
|
|
2015
Q3 | $4.27M | Sell |
121,349
-11,300
| -9% | -$509K | ﹤0.01% | 1124 |
|
|
2015
Q2 | $6.09M | Buy |
132,649
+4,300
| +3% | +$204K | 0.01% | 1041 |
|
|
2015
Q1 | $6.02M | Buy |
128,349
+300
| +0.2% | +$11.9K | ﹤0.01% | 1039 |
|
|
2014
Q4 | $4.06M | Buy |
128,049
+12,700
| +11% | +$372K | ﹤0.01% | 1235 |
|
|
2014
Q3 | $2.73M | Sell |
115,349
-15,200
| -12% | -$389K | ﹤0.01% | 1484 |
|
|
2014
Q2 | $3.92M | Sell |
130,549
-4,198
| -3% | -$113K | ﹤0.01% | 1278 |
|
|
2014
Q1 | $3.56M | Buy |
134,747
+57
| +0% | +$1.43K | ﹤0.01% | 1324 |
|
|
2013
Q4 | $3.39M | Sell |
134,690
-23,494
| -15% | -$524K | ﹤0.01% | 1354 |
|
|
2013
Q3 | $3.24M | Sell |
158,184
-1
| -0% | -$21 | ﹤0.01% | 1337 |
|
|
2013
Q2 | $3.16M | Buy |
+158,185
| New | +$2.81M | ﹤0.01% | 1291 |
|
AllianceBernstein's IPXL Position: Q2 2018 in Review
AllianceBernstein sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 113,249 shares — an estimated $2.2M sold.
AllianceBernstein first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $6.09M in Q2 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- AllianceBernstein reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- AllianceBernstein sold 113,249 Impax Laboratories, Inc. shares in Q2 2018, an estimated $2.2M.
- AllianceBernstein first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
- AllianceBernstein's Impax Laboratories, Inc. position peaked at $6.09M in Q2 2015.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on AllianceBernstein's 13F filing for Q2 2018, filed 13 Aug 2018.